Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT04861506 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

The Safety and Efficiency of Endovascular Treatment of Acute or Subacute Thromboembolic Occlusions of Lower Extremity.

StatusRecruiting
PhaseNot specified
Started
View on ClinicalTrials.gov ↗
Record status
This record was last updated September 15, 2025 (before its estimated December 31, 2025 completion). Its status may not reflect the trial's current state.

Record History

See every version on ClinicalTrials.gov ↗

  1. Eligibility criteria shortened, about 13 wordsv3
  2. Primary completion date: Dec 31, 2023 to Dec 31, 2025
    • Start date: Jan 1, 2021 to Apr 1, 2021
    • Secondary endpoints: details revised at 4 of 7 entries
    • Eligibility criteria expanded, about 4 words
    v2
  3. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
Based on the development of new tools, including drug coated balloon, paclitaxel eluting stent, interwoven stents, debulking tools, More and more acute or subacute thromboembolic occlusions of lower extremity included stage IIb were treated with endovascular procedures. Most guidelines suggests only stage I and stage IIa lesions are suitable for endovascular treatments. Therefore, a well-designed real-world study that track the safety and clinical relevant outcomes, are required to determine the optimal therapies for patients with acute or subacute thromboembolic occlusions of lower extremity.
Trial Details
NCT Number NCT04861506
Lead Sponsor First People's Hospital of Hangzhou
Collaborators: RenJi Hospital, First Affiliated Hospital of Zhejiang University, Xuanwu Hospital, Beijing, Qingdao Haici Hospital, Liyuan Hospital of Tongji Medical College, Huazhong University of Science and Technology, Second Affiliated Hospital of Suzhou University, Chengdu University of Traditional Chinese Medicine, Shanghai Zhongshan Hospital
Conditions
(from sponsor)		 Thromboembolic Disease, Lower Extremity Problem, Endovascular Treatment, Safety Issues, Efficacy, Self
Related terms Thromboembolism
Enrollment 400 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov